PortfoliosLab logoPortfoliosLab logo
ISIN
US00214Q3020
CUSIP
00214Q302
Issuer
ARK
Inception Date
Oct 31, 2014
Region
Global (Broad)
Leveraged
1x (No leverage)
Index Tracked
No Index (Active)
Domicile
United States
Distribution Policy
Accumulating
Asset Class
Equity
Asset Class Size
Multi-Cap
Asset Class Style
Growth
Assets Under Management
$1B

Share Price Chart


Loading charts...

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Performance

ARKG Performance Chart

ARK Genomic Revolution Multi-Sector ETF (ARKG) is up 25.7% since the beginning of the year. ARKG is currently trading at $36 per share. Investors who bought $1,000 worth of ARKG shares 5 years ago would now be looking at an investment worth $414.


Loading charts...

S&P 500 Index

Returns By Period

ARK Genomic Revolution Multi-Sector ETF (ARKG) has returned 25.65% so far this year and 52.94% over the past 12 months. Over the last ten years, ARKG has returned 8.79% per year, falling short of the S&P 500 Index benchmark, which averaged 13.88% annually.


ARK Genomic Revolution Multi-Sector ETF

1D
-1.25%
1M
18.68%
YTD
25.65%
6M
18.88%
1Y
52.94%
3Y*
3.54%
5Y*
-16.18%
10Y*
8.79%

Benchmark (S&P 500 Index)

1D
-0.37%
1M
-0.01%
YTD
9.16%
6M
8.64%
1Y
25.22%
3Y*
19.78%
5Y*
11.99%
10Y*
13.88%
*Multi-year figures are annualized to reflect compound growth (CAGR)

ARKG Monthly Returns History

Based on dividend-adjusted daily data since Oct 31, 2014, ARKG's average daily return is +0.05%, while the average monthly return is +0.99%. At this rate, an investment would double in approximately 5.9 years.

Historically, 49% of months were positive and 51% were negative. The best month was Apr 2020 with a return of +30.1%, while the worst month was Apr 2022 at -26.0%. The longest winning streak lasted 10 consecutive months, and the longest losing streak was 8 months.

On a daily basis, ARKG closed higher 52% of trading days. The best single day was Apr 9, 2025 with a return of +12.1%, while the worst single day was Mar 16, 2020 at -13.8%.


JanFebMarAprMayJunJulAugSepOctNovDecTotal
20265.04%-1.48%-11.87%13.06%15.97%5.08%25.65%
202513.99%-8.27%-15.68%5.92%-4.87%16.40%-2.18%3.78%12.34%12.10%0.19%-7.12%23.04%
2024-13.32%10.79%-8.73%-19.02%5.20%-4.16%14.78%-2.08%-2.99%-9.61%12.27%-9.37%-28.24%
202319.38%-9.94%-0.92%-3.69%9.22%7.78%11.47%-15.13%-13.61%-17.37%20.50%18.28%16.22%
2022-18.84%-2.66%-5.06%-25.97%-5.12%-2.39%16.26%-3.06%-7.38%2.71%-3.73%-13.14%-53.90%
20219.30%-8.26%-5.11%0.16%-8.01%13.15%-8.81%1.58%-12.79%0.51%-15.62%-2.75%-33.92%

Benchmark Metrics

ARK Genomic Revolution Multi-Sector ETF has an annualized alpha of -4.60%, beta of 1.40, and R2 of 0.39 versus S&P 500 Index. Calculated based on daily prices since October 31, 2014.

  • This ETF participated in 165.07% of S&P 500 Index downside but only 147.08% of its upside - more exposed to losses than it benefited from rallies.
  • R2 of 0.39 means the benchmark explains less than half of this ETF's behavior - treat beta with caution or consider switching to a more representative benchmark.

Alpha
-4.60%
Beta
1.40
0.39
Upside Capture
147.08%
Downside Capture
165.07%

Expense Ratio

ARKG has an expense ratio of 0.75%, placing it in the medium range.


Return for Risk

Risk / Return Rank

ARKG ranks 36 for risk / return — below 36% of ETFs on our site. The returns aren't fully compensating for the risk involved. This isn't necessarily a dealbreaker, but factor it into your decision — especially if you're risk-averse.


ARKG Risk / Return Rank: 3636
Overall Rank
ARKG Sharpe Ratio Rank: 3636
Sharpe Ratio Rank
ARKG Sortino Ratio Rank: 3838
Sortino Ratio Rank
ARKG Omega Ratio Rank: 3333
Omega Ratio Rank
ARKG Calmar Ratio Rank: 4040
Calmar Ratio Rank
ARKG Martin Ratio Rank: 3333
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

Return / Risk — by metrics

The table below present risk-adjusted performance metrics for ARK Genomic Revolution Multi-Sector ETF (ARKG) and compare them to S&P 500 Index.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.


ARKGBenchmarkDifference
Sharpe ratioReturn per unit of total volatility

-0.78

Sortino ratioReturn per unit of downside risk

-0.83

Omega ratioGain probability vs. loss probability

1.22

1.37

-0.15

Calmar ratioReturn relative to maximum drawdown

1.93

2.78

-0.85

Martin ratioReturn relative to average drawdown

4.60

12.44

-7.83

Dividends

Dividend History

ARK Genomic Revolution Multi-Sector ETF provided a 0.00% dividend yield over the last twelve months, with an annual payout of $0.00 per share.


0.00%0.50%1.00%1.50%2.00%2.50%3.00%3.50%$0.00$0.20$0.40$0.60$0.80$1.00201720182019202020212022202320242025
Dividends
Dividend Yield
PeriodTTM202520242023202220212020201920182017
Dividend$0.00$0.00$0.00$0.00$0.00$0.38$0.79$1.05$0.20$0.33

Dividend yield

0.00%0.00%0.00%0.00%0.00%0.62%0.85%3.14%0.82%1.34%

Monthly Dividends

The table displays the monthly dividend distributions for ARK Genomic Revolution Multi-Sector ETF. The dividends shown in the table have been adjusted to account for any splits that may have occurred.


JanFebMarAprMayJunJulAugSepOctNovDecTotal
2026$0.00$0.00$0.00$0.00$0.00$0.00$0.00
2025$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00
2024$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00
2023$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00
2022$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00
2021$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.38$0.38

Drawdowns

Drawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.


Loading charts...

Worst Drawdowns

The table below displays the maximum drawdowns of the ARK Genomic Revolution Multi-Sector ETF. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the ARK Genomic Revolution Multi-Sector ETF was 83.59%, occurring on Apr 8, 2025. The portfolio has not yet recovered.

The current ARK Genomic Revolution Multi-Sector ETF drawdown is 67.43%.


Related event

Drawdown

Fall

Recovery

Underwater

2025 selloff2025
-83.59%Apr 2025
4y 2mo
5y 5moJan 2021 - now
2016 bear market2016
-37.44%Feb 2016
7mo 23d1y 6mo
2y 2moJun 2015 - Aug 2017
Rate-hike selloffLate 2018
-35.09%Dec 2018
3mo 18d3mo 13d
7mo 1dSep 2018 - Apr 2019
COVID crash2020
-34.99%Mar 2020
7d1mo 5d
1mo 12dMar 2020 - Apr 2020
2019 bear market2019
-20.71%Oct 2019
2mo 9d2mo 10d
4mo 19dJul 2019 - Dec 2019

Drawdown Indicators


ARKGBenchmarkDifference

Max Drawdown

Largest peak-to-trough decline

-83.59%

-56.78%

-26.81%

Max Drawdown (1Y)

Largest decline over 1 year

-27.51%

-9.10%

-18.41%

Max Drawdown (3Y)

Largest decline over 3 years

-51.96%

-18.90%

-33.06%

Max Drawdown (5Y)

Largest decline over 5 years

-80.18%

-25.43%

-54.75%

Max Drawdown (10Y)

Largest decline over 10 years

-83.59%

-33.92%

-49.67%

Current Drawdown

Current decline from peak

-67.43%

-1.80%

-65.63%

Average Drawdown

Average peak-to-trough decline

-36.00%

-10.71%

-25.29%

Ulcer Index

Depth and duration of drawdowns from previous peaks

11.53%

2.03%

+9.50%

Volatility

Volatility Chart

The chart below shows the rolling one-month volatility.


Loading charts...

Portfolio Analyzer

Build a portfolio with ARKG

Add ARK Genomic Revolution Multi-Sector ETF to a portfolio and analyze allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Analyzer with ARKG